BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG AND Treatment
7 results:

  • 1. pparg is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics.
    Zhang T; Chen X; Ju X; Yuan J; Zhou J; Zhang Z; Ju G; Xu D
    Eur J Med Res; 2023 Nov; 28(1):487. PubMed ID: 37932808
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
    Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z
    Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced prostate cancer: A National Population-Based Study Using Patient-Reported Outcomes.
    Parry MG; Nossiter J; Cowling TE; Sujenthiran A; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1196-1203. PubMed ID: 32717261
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recurrent activating mutations of PPARγ associated with luminal bladder tumors.
    Rochel N; Krucker C; Coutos-Thévenot L; Osz J; Zhang R; Guyon E; Zita W; Vanthong S; Hernandez OA; Bourguet M; Badawy KA; Dufour F; Peluso-Iltis C; Heckler-Beji S; Dejaegere A; Kamoun A; de Reyniès A; Neuzillet Y; Rebouissou S; Béraud C; Lang H; Massfelder T; Allory Y; Cianférani S; Stote RH; Radvanyi F; Bernard-Pierrot I
    Nat Commun; 2019 Jan; 10(1):253. PubMed ID: 30651555
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
    Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transcriptional regulatory networks in human lung adenocarcinoma.
    Meng X; Lu P; Bai H; Xiao P; Fan Q
    Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.